Maggie Cheang

Title: Innovations in Breast Cancer Classification by Maggie Cheang

Introduction

Maggie Cheang is a notable inventor based in Vancouver, Canada. She has made significant contributions to the field of breast cancer research through her innovative methods for classifying breast cancer intrinsic subtypes. Her work aims to improve the prognosis and treatment options for patients diagnosed with breast cancer.

Latest Patents

Maggie Cheang holds a patent for a method of classifying a breast cancer intrinsic subtype. This patent, which includes 1 patent, outlines methods for evaluating the prognosis of a subject with breast cancer. The techniques involve predicting breast cancer subtypes using a supervised algorithm trained to stratify subjects based on their intrinsic subtype. The prediction model relies on the gene expression profile of intrinsic genes, allowing for accurate predictions of a subject's breast cancer subtype. Additionally, the methods provide compositions for predicting outcomes or responses to therapy, which can guide treatment options for patients.

Career Highlights

Throughout her career, Maggie Cheang has worked with esteemed organizations such as the University of Utah Research Foundation and the British Columbia Cancer Agency Branch. Her research has been pivotal in advancing the understanding of breast cancer and improving patient care.

Collaborations

Maggie has collaborated with prominent researchers in her field, including Charles M. Perou and Joel S. Parker. These collaborations have further enhanced the impact of her work on breast cancer classification and treatment.

Conclusion

Maggie Cheang's innovative methods for classifying breast cancer intrinsic subtypes represent a significant advancement in cancer research. Her contributions are vital for improving patient outcomes and guiding treatment decisions in breast cancer care.